Recent CDC FluSurv-NET and NHSN surveillance through late August 2026 shows influenza-associated hospitalization rates holding steady at 0.1–0.2 per 100,000 population during weeks 32–33, consistent with typical off-season minima when community transmission is minimal. Week 34 falls in the same low-activity window before typical fall upticks, with virologic positivity below 1% and no evidence of early seasonal acceleration. Market-implied odds near parity around the 0.1 threshold reflect uncertainty from preliminary reporting lags, small week-to-week fluctuations in confirmed admissions, and potential minor revisions once full data arrive. Historical analogs indicate rates this late in summer rarely deviate far from baseline surveillance noise, keeping trader focus on whether the final adjusted figure lands precisely at, below, or above the resolution cutoff.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · ОбновленоКоэффициент госпитализации в связи с гриппом, неделя 34, 2026?
Коэффициент госпитализации в связи с гриппом, неделя 34, 2026?
0,1 50%
<0,1 45%
>0,1 45%
НОВОЕ
НОВОЕ
4 сент. 2026 г.
<0,1
45%
0,1
50%
>0,1
45%
0,1 50%
<0,1 45%
>0,1 45%
НОВОЕ
НОВОЕ
4 сент. 2026 г.
<0,1
$0 Объем
45%
0,1
$0 Объем
50%
>0,1
$0 Объем
45%
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Recent CDC FluSurv-NET and NHSN surveillance through late August 2026 shows influenza-associated hospitalization rates holding steady at 0.1–0.2 per 100,000 population during weeks 32–33, consistent with typical off-season minima when community transmission is minimal. Week 34 falls in the same low-activity window before typical fall upticks, with virologic positivity below 1% and no evidence of early seasonal acceleration. Market-implied odds near parity around the 0.1 threshold reflect uncertainty from preliminary reporting lags, small week-to-week fluctuations in confirmed admissions, and potential minor revisions once full data arrive. Historical analogs indicate rates this late in summer rarely deviate far from baseline surveillance noise, keeping trader focus on whether the final adjusted figure lands precisely at, below, or above the resolution cutoff.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Открытие рынка: Aug 28, 2026, 11:04 AM ET
Объем
$0Дата окончания
4 сент. 2026 г.Открытие рынка
Aug 28, 2026, 11:04 AM ETКто определяет исход
0x69c47De9D...This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.Recent CDC FluSurv-NET and NHSN surveillance through late August 2026 shows influenza-associated hospitalization rates holding steady at 0.1–0.2 per 100,000 population during weeks 32–33, consistent with typical off-season minima when community transmission is minimal. Week 34 falls in the same low-activity window before typical fall upticks, with virologic positivity below 1% and no evidence of early seasonal acceleration. Market-implied odds near parity around the 0.1 threshold reflect uncertainty from preliminary reporting lags, small week-to-week fluctuations in confirmed admissions, and potential minor revisions once full data arrive. Historical analogs indicate rates this late in summer rarely deviate far from baseline surveillance noise, keeping trader focus on whether the final adjusted figure lands precisely at, below, or above the resolution cutoff.
This market will resolve according to the weekly influenza-associated hospitalization rate per 100,000 population for the United States, as reported by CDC FluSurv-NET for the specified week.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
The resolution source for this market will be CDC FluView / FluSurv-NET (see: https://www.cdc.gov/fluview/index.html). If the FluSurv-NET hospitalization rate for the specified week is not released by 11:59 PM ET on the tenth calendar day following the date of the prior FluView weekly report release, this market will resolve to the lowest bracket.
CDC FluView reports the weekly FluSurv-NET hospitalization rate per 100,000 population to one decimal point (e.g., 0.1). Thus, this is the level of precision that will be used when resolving the market.
Note: Only the CDC FluSurv-NET weekly hospitalization rate per 100,000 population for the specified week will qualify, regardless of the cumulative influenza-associated hospitalization rate, estimates, projections, state-level reports, or other influenza surveillance metrics published by the CDC or other sources.
Объем
$0Дата окончания
4 сент. 2026 г.Открытие рынка
Aug 28, 2026, 11:04 AM ETКто определяет исход
0x69c47De9D...Recent CDC FluSurv-NET and NHSN surveillance through late August 2026 shows influenza-associated hospitalization rates holding steady at 0.1–0.2 per 100,000 population during weeks 32–33, consistent with typical off-season minima when community transmission is minimal. Week 34 falls in the same low-activity window before typical fall upticks, with virologic positivity below 1% and no evidence of early seasonal acceleration. Market-implied odds near parity around the 0.1 threshold reflect uncertainty from preliminary reporting lags, small week-to-week fluctuations in confirmed admissions, and potential minor revisions once full data arrive. Historical analogs indicate rates this late in summer rarely deviate far from baseline surveillance noise, keeping trader focus on whether the final adjusted figure lands precisely at, below, or above the resolution cutoff.
Экспериментальная сводка, созданная ИИ на основе данных Polymarket. Это не является торговой рекомендацией и не влияет на то, как разрешается этот рынок. · Обновлено
Не доверяй внешним ссылкам.
Не доверяй внешним ссылкам.
Часто задаваемые вопросы